Cargando…
A Promising Approach to Treat Psoriasis: Inhibiting Cytochrome P450 3A4 Metabolism to Enhance Desoximetasone Therapy
(1) Background: Human keratinocytes and murine skin express various cytochrome P450 enzymes. These include cytochrome P450 3A4, which may participate in the metabolism of cytochrome P450 3A4 substrate drugs. Desoximetasone, a topical corticosteroid and cytochrome P450 3A4 substrate, is used to treat...
Autores principales: | Guo, Jiun-Wen, Cheng, Yu-Pin, Lim, Cherng-Jyr, Liu, Chih-Yi, Jee, Shiou-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458942/ https://www.ncbi.nlm.nih.gov/pubmed/37631230 http://dx.doi.org/10.3390/pharmaceutics15082016 |
Ejemplares similares
-
Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone
por: Shah, Parinbhai, et al.
Publicado: (2021) -
A Comparative Evaluation of Desoximetasone Cream and Ointment Formulations Using Experiments and In Silico Modeling
por: Matharoo, Namrata S., et al.
Publicado: (2023) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
por: Wang, Hao, et al.
Publicado: (2020) -
Magnolol may contribute to barrier function improvement on imiquimod-induced psoriasis-like dermatitis animal model via the downregulation of interleukin-23
por: Guo, Jiun-Wen, et al.
Publicado: (2021) -
Cytochrome P450 Enzymes and Drug Metabolism in Humans
por: Zhao, Mingzhe, et al.
Publicado: (2021)